AwesomeCapital
Search This Blog
Wednesday, December 20, 2023
Enlivex to Start Phase II Trial Evaluating Allocetra In Patients With Sepsis
Enrollment completed in placebo-controlled, randomized, dose-finding, multi-country, multi-center Phase II sepsis study
Topline Data Expected in late Q1 2024
https://www.globenewswire.com/news-release/2023/12/20/2799218/0/en/Enlivex-Announces-Completion-of-Enrollment-of-Its-Phase-II-Trial-Evaluating-Allocetra-In-Patients-With-Sepsis.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.